The effect of the phytoestrogen coumestrol on the NZB/W F1 murine model of systemic lupus

被引:16
|
作者
Schoenroth, LJ
Hart, DA
Pollard, KM
Fritzler, MJ
机构
[1] Univ Calgary, Fac Med, Calgary, AB T2N 4N1, Canada
[2] Scripps Res Inst, Wm Keck Autoimmune Dis Ctr, La Jolla, CA 92037 USA
基金
加拿大健康研究院;
关键词
autoimmunity; coumestrol; systemic lupus; phytoestrogen;
D O I
10.1016/j.jaut.2004.09.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Coumestrol is a naturally occurring plant estrogen. As estrogen influences cellular and humoral immunity, and has known effects on murine models of lupus, we investigated the effect of coumestrol on disease expression in the NZB/W F1 mouse. Female NZB/W F1 mice were fed a "standard" rodent diet including soy proteins, a non-soy diet, or a non-soy diet with 0.01% coumestrol. Outcome measures included survival, autoantibody expression, immunoglobulin levels, proteinuria, renal histology and B cell imimmohistochemistry, and renal mRNA expression. At 24 weeks, the treatment group had decreased prevalence of autoantibodies detected by immunofluorescence and less splenomegaly. At 39 weeks, the prevalence of autoantibodies was similar but the treatment group had less proteinuria. Overall, there was little effect of treatment on renal mRNA levels as assessed by gene array analysis, but functional ontology mapping revealed that genes encoding proteins involved in the immune response were most often affected. These results suggest that treatment with coumestrol may ameliorate some aspects of disease progression in this model of systemic autoinamunity. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:323 / 332
页数:10
相关论文
共 50 条
  • [21] Anti-vascular endothelial growth factor receptor-2 antibody accelerates renal disease in the NZB/W F1 murine systemic lupus erythematosus model
    Watanabe, H
    Mamelak, AJ
    Weiss, E
    Wang, B
    Freed, I
    Brice, AK
    Wachtman, L
    Gabrielson, KL
    Yokota, N
    Hicklin, DJ
    Kerbel, RS
    Haas, M
    Sauder, DN
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 407 - 409
  • [22] Similarity and difference between systemic lupus erythematosus and NZB/W F1 mice by multi-omics analysis
    Okuma, Kenji
    Oku, Takuma
    Sasaki, Chiyomi
    Kitagori, Koji
    Mimori, Tsuneyo
    Aramori, Ichiro
    Hirayama, Yoshitaka
    Yoshifuji, Hajime
    MODERN RHEUMATOLOGY, 2024, 34 (02) : 359 - 368
  • [23] Effects of Fasudil Treatment on Lupus Pathogenesis in NZB/W F1 Female Mice
    Stirzaker, Roslynn A.
    Biswas, Partha S.
    Gupta, Sanjay
    Yuan, Weijia
    Song, Li
    Chandrasekaran, Uma
    Bhagat, Govind
    Pernis, Alessandra B.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S216 - S216
  • [24] Prevention of murine lupus disease in (NZB x NZW)F1 mice by sirolimus treatment
    Ramos-Barron, A.
    Pinera-Haces, C.
    Gomez-Alamillo, C.
    Santiuste-Torcida, I.
    Ruiz, J. C.
    Buelta-Carrillo, L.
    Merino, R.
    de Francisco, A. L. M.
    Arias, M.
    LUPUS, 2007, 16 (10) : 775 - 781
  • [25] Pristane alters the phenotype of genetically determined lupus in (NZB/W) F1 mice.
    Yoshida, H
    Satoh, M
    Shaw, M
    Shaheen, VM
    Richards, HB
    Reeves, WH
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S384 - S384
  • [26] Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand
    Nakajima, A
    Hirai, H
    Kayagaki, N
    Yoshino, S
    Hirose, S
    Yagita, H
    Okumura, K
    JOURNAL OF AUTOIMMUNITY, 2000, 14 (02) : 151 - 157
  • [27] Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model
    Borel, Paula
    Benkhoucha, Mahdia
    Weber, Martin S.
    Zamvil, Scott S.
    Santiago-Raber, Marie-Laure
    Lalive, Patrice H.
    INTERNATIONAL IMMUNOLOGY, 2008, 20 (10) : 1313 - 1319
  • [28] Fecal microbiota changes in NZB/W F1 mice after induction of lupus disease
    Yen-Fu Chen
    Ao-Ho Hsieh
    Lian-Chin Wang
    Yun-Ju Huang
    Wen-Yi Yun-Chen Tsai
    Yu-Lun Tseng
    Shue-Fen Kuo
    Kuang-Hui Luo
    Chang-Fu Yu
    Scientific Reports, 11
  • [29] Soluble human CD83 ameliorates lupus in NZB/W F1 mice
    Starke, Charlotte
    Steinkasserer, Alexander
    Voll, Reinhard E.
    Zinser, Elisabeth
    IMMUNOBIOLOGY, 2013, 218 (11) : 1411 - 1415
  • [30] Effects of Shikonin Isolated from Zicao on Lupus Nephritis in NZB/W F1 Mice
    Wang, Xin Chang
    Feng, Jian
    Huang, Feng
    Fan, Yong Sheng
    Wang, Yan Yan
    Cao, Ling Yong
    Wen, Cheng Pin
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (09) : 1565 - 1570